
ONKOCET Ltd. has exhibited the devices from its portfolio on the MEDTEC UK exhibition in Birmingham, April 2011 through our partner Medical & Partners.

The ONKOCET company has successfully reached the certification of yet another medical device, Infrared Camera SVIT. The Certificate can be found here. The videos from the device operation can be found here.
Our device, the non-invasive blood analyzer AMP has won the Golden Incheba prize at a medical exhibition SLOVMEDICA - NON-HANDICAP 2010. A big thank you goes to the organizers of the exhibition for acknowledging the quality of our device and to the exhibitor, the Medical & Partners company, for introduction of the AMP device to the medical public again.
You can find the certificate here.
Our company has finished the certification process for another medical device, computerized spirometer MAS-1K with oximeter. You can find the device certificate here.
Since May 2010 there is a new version of AMP device available.
Dear partners, .gif)

Program “Asthma- monitor” was for the first time represented on May 27, 2008 at the provincial pulmonary conference in city Grodno (“Grodnensk provincial clinical hospital”).
Program “Asthma- monitor” is installed in any MAS-1 spirometer with the color picture screen and is intended for the daily monitoring of PEF and FEV1 of patients under the conditions of hospital (pulmonary, allergological departments). The graph of monitoring is accessible both on the screen of instrument and in the printed protocol of the A4 size. It communicates automatically about the diagnostically significant cases with the daily variability of PEF, FEV1 exceeding standard. On the basis of conventional children's and adult test- questionnaires on the control over asthma (Asthma Control TestTM) into the printed protocol is derived also mark on the control over asthma with the interpretation. Data of monitoring are stored in the energy-independent memory of instrument and can be used as needed, for example, for the repeated hospitalization for the purpose of the selection of pharmacotherapy.